ANCA-Associated Vasculitis: Pathogenesis, Models, and Preclinical Testing.

Area of Science:

• Immunology
• Rheumatology
• Pathogenesis of autoimmune diseases

Background:

• Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) understanding has evolved since ANCA discovery in 1982.
• ANCA targets neutrophil components, playing roles in diagnosis, monitoring, and microvascular injury.
• Advances in human disease observation and experimental models have refined knowledge of AAV immunopathogenesis.

Purpose of the Study:

• To review the pathogenesis of ANCA-associated vasculitis.
• To highlight challenges in identifying novel, less-toxic treatments for AAV.
• To discuss potential therapeutic targets and future research directions.

Main Methods:

• Review of human disease observations.
• Analysis of in vitro and in vivo studies, including rodent models.
• Synthesis of current understanding of leukocyte recruitment, tissue injury, T cell roles, and complement involvement.

Main Results:

• A nuanced understanding of AAV immunopathogenesis has been achieved.
• The diagnostic and monitoring significance of ANCA is established.
• ANCA's role as a mediator of microvascular injury is recognized.
• The involvement of T cells and complement in disease mechanisms is increasingly understood.

Conclusions:

• Significant progress has been made in understanding ANCA-associated vasculitis.
• Developing less-toxic treatments and identifying therapeutic targets remain key challenges.
• Further research using existing and future models is crucial for advancing AAV management.